2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis - Wikidata - awgldk - TriplyDB

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

http://www.wikidata.org/entity/Q24603648

about

Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study Phosphodiesterase 4-targeted treatments for autoimmune diseases Defects in tendon, ligament, and enthesis in response to genetic alterations in key proteoglycans and glycoproteins: a review Decreased plasma levels of soluble CD18 link leukocyte infiltration with disease activity in spondyloarthritis Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)Self management programme for ankylosing spondylitis Sulfasalazine for ankylosing spondylitis Exercise therapy for ankylosing spondylitis Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials Secukinumab for rheumatology: development and its potential place in therapy Clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology Concurrent Intervention With Exercises and Stabilized Tumor Necrosis Factor Inhibitor Therapy Reduced the Disease Activity in Patients With Ankylosing Spondylitis: A Meta-Analysis Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies Old and new treatment targets in axial spondyloarthritis Use of biologics in SLE: a review of the evidence from a clinical perspective Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations New targets in psoriatic arthritis Integrative structural biomechanical concepts of ankylosing spondylitis Physical activity assessment in patients with axial spondyloarthritis compared to healthy controls: a technology-based approach Expression of Prostaglandin E2 Enzymes in the Synovium of Arthralgia Patients at Risk of Developing Rheumatoid Arthritis and in Early Arthritis Patients Should axial spondyloarthritis without radiographic changes be treated with anti-TNF agents?Is there a role for sulphasalazine in axial spondyloarthritis in the era of TNF inhibition? Data from the NOR-DMARD longitudinal observational study.American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.Development of a web-based patient decision aid for initiating disease modifying anti-rheumatic drugs using user-centred design methods.Long-term efficiency of infliximab in patients with ankylosing spondylitis: real life data confirm the potential for dose reduction Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability.Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study Etanercept in the treatment of ankylosing spondylitis: A systematic review and meta-analysis.Referral patterns, diagnosis, and disease management of patients with axial spondyloarthritis: results of an international survey Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.Short term in-patient rehabilitation in axial spondyloarthritis - the results of a 2-week program performed in daily clinical practice Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis.Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study.Randomized controlled trial of a nurse-led rheumatology clinic for monitoring biological therapy.Spontaneous, drug-induced, and drug-free remission in peripheral and axial spondyloarthritis.Management of arthropathy in inflammatory bowel diseases.Increased risk of ischemic stroke in young patients with ankylosing spondylitis: a population-based longitudinal follow-up study.

P2860

Q21195256-F29B96AC-3416-4CF9-AD30-21E6F6996854 Q21245284-2859F587-E3A1-4F73-97D2-D5133D568FBF Q21285116-947F6286-62BF-4B70-A7F1-4BAB3C0064CE Q22000831-89BE8D7E-5FCA-41D3-9457-05141D9BE851 Q24186403-25CB596F-2D83-4D91-B83C-A660DB2C0196 Q24187492-C4389A63-1E9B-4853-83D9-F9950ECD947D Q24187791-0C9F817E-4F71-432B-B555-19968B3821D6 Q24193372-0DD0264D-8FF6-4F62-BBC4-C659C1F77DF4 Q24201300-506E3F67-FFFD-4D0C-BDB4-5E1490603450 Q26738520-3CA4C661-7D2D-4EDF-AEDD-F606F38D3230 Q26738523-EA1328F5-D5B6-41F3-B25E-3D955223BF30 Q26766028-B5C4823E-05EE-4D38-8AE1-2196E86923C7 Q26774738-29B76F6B-FF45-49B1-9E8A-82E1CC92FD2A Q26777084-427316BB-318F-45F9-9541-5A80306FF2E1 Q26777906-242DCFFA-8DFB-44AA-B20E-97BD6E95DBA5 Q26783652-9ACEAB0D-17F3-45C2-8FBB-84AFA5E87A01 Q26784247-D2AA7391-1DA8-47B5-94DC-5C4AD382BC4A Q28069592-F3A573C6-5DDF-4B2C-8FD4-7FB2E5C3AAF7 Q28395076-66157390-30E7-42B4-B08D-F923C5BA52CA Q28396710-A48D86D1-0EEC-4A71-B215-89B60230B948 Q28546899-4F851F1B-DD18-4B8D-B6E0-8975188FD4A7 Q30239856-E462F986-6EC7-4938-9A8D-1E6ED18DFA93 Q30750448-7DED34F7-7D52-4EE3-B3A5-17C43DD7BD8A Q30829836-15A2A54B-C686-4E94-BB55-A91D58D6024D Q30847028-4696F03C-84A1-40CD-BB01-EFA2AD97702E Q31119751-88ACF997-28E1-4A02-8221-311E80991AD7 Q33740641-8470CEC3-03D7-463C-934F-50678C0CA0A3 Q33809045-986CB52E-9DCC-4D33-8334-927CC3C8B711 Q33881234-E6070FD9-83F9-4C58-819E-7F1BDD74B11B Q34277511-CA2D3335-5FDD-4090-BBC0-6FA07C4188AD Q34292245-09C856AC-E2F6-4C3C-A410-ECD4FCA79481 Q34570459-FF003CBF-8DAE-4EA3-9905-503970A1D66F Q34570563-50E2463E-A15A-4276-944C-97C6CFD4D679 Q34708922-BB58C0E5-76A4-4C8F-9B6E-9B5277A824F5 Q34728162-B951DA7E-07D9-44D2-B729-58C9D9C7ED33 Q34808170-9AB813E3-4973-48E7-A517-233AE7732EBA Q34850808-7F5CA82D-4696-4320-B3DC-DFEAE41FE0B0 Q34894874-E6339355-FCDF-4F6B-94DD-151BA40E9D66 Q35091366-F28F8E7F-1B85-4F49-8439-0389578D7749 Q35142805-89DD2720-FD61-4FE5-8F8A-BE6E2EA45A3E

P2860

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

http://www.wikidata.org/entity/Q24603648

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

2010 update of the ASAS/EULAR ...... ment of ankylosing spondylitis

@ast

2010 update of the ASAS/EULAR ...... ment of ankylosing spondylitis

@en

2010 update of the ASAS/EULAR ...... ment of ankylosing spondylitis

@en-gb

2010 update of the ASAS/EULAR ...... ment of ankylosing spondylitis

@nl

type

label

2010 update of the ASAS/EULAR ...... ment of ankylosing spondylitis

@ast

2010 update of the ASAS/EULAR ...... ment of ankylosing spondylitis

@en

2010 update of the ASAS/EULAR ...... ment of ankylosing spondylitis

@en-gb

2010 update of the ASAS/EULAR ...... ment of ankylosing spondylitis

@nl

prefLabel

2010 update of the ASAS/EULAR ...... ment of ankylosing spondylitis

@ast

2010 update of the ASAS/EULAR ...... ment of ankylosing spondylitis

@en

2010 update of the ASAS/EULAR ...... ment of ankylosing spondylitis

@en-gb

2010 update of the ASAS/EULAR ...... ment of ankylosing spondylitis

@nl

P1433

Q24603648-D3E40ABE-C349-44D2-A277-288F9E2C5048

P1476

Q24603648-2086157D-D9AD-46B4-A0D6-46FDE13646B8

P2093

Q24603648-020FB8A9-EA7E-4882-BFF2-DC5E972F01AB

Q24603648-126AF3E4-779E-40C5-9F1D-5E3CFC8EB410

Q24603648-23D2DB7E-09D9-4EF7-A987-4CEC12E9716E

Q24603648-3FF81FCA-0801-4FE9-913A-3F70FED576EB

Q24603648-47BB2D85-702A-46FF-9EBC-284EEC8724AD

Q24603648-4A0AAF87-0271-4AFA-8473-A203B3603E9F

Q24603648-6DF001C4-1101-4E26-8033-7E52F10939B5

Q24603648-701F0C13-5C7D-43E3-804E-794B8FCED3CE

Q24603648-7493BA52-92EA-4704-A2A4-DA12A104A2AC

Q24603648-7E5869B1-B2BC-49A4-BFC9-950C4B9F90DD

P275

Q24603648-9233FBCB-6B92-4E9D-B64E-837DA41A389A

P2860

Q24603648-00B4BC0F-F253-4EB7-9773-661754997D62

Q24603648-04257AE1-59FD-49F7-8ED6-DFB017A60BC4

Q24603648-072212DF-CE47-4548-AC71-5CA7BB1D0ACE

Q24603648-08F47B84-E5D7-424C-B826-9C450C244C5F

Q24603648-09600BAE-873D-46B7-B1F9-7F8F401362F0

Q24603648-0DAEF5BC-F095-4050-930A-5887685D0DFE

Q24603648-14EF973E-DC61-4442-801B-D42F0E6E4E75

Q24603648-1AEDD384-E929-41A2-98F7-B5D5164FF83A

Q24603648-1BD8C250-5E0F-425A-AD05-B2AFB873FDC4

Q24603648-1C854A15-EB6E-4A74-8CBE-30722F101BC1

P304

Q24603648-5924613C-ABF8-45EB-A0F1-9B3E7E9974D5

P31

Q24603648-6A9B2282-CABA-4A7B-B3A3-EAF077E5A3B2

Q24603648-A3326707-CBFF-4ED9-9678-2C1817CA68D5

P3181

Q24603648-7BFC65FC-D817-4A2B-AF8B-146EA07BB2AB

P356

Q24603648-880419D2-01F6-442B-BF1A-D6B242408BD2

P407

Q24603648-7458191F-0EDA-48A8-9C61-7DC72D4D87F7

P433

Q24603648-BD81582B-CDB2-4903-998A-7E99504FF208

P478

Q24603648-D7EE71A2-486F-43AB-ABE5-EA2122885511

P50

Q24603648-14572251-69F4-4FA7-BF1D-6EEDB3CD0023

Q24603648-907B8E33-FE1C-4E98-A8BA-3B9DB949CC62

Q24603648-9CF746F8-A11F-41B3-81A9-C31C76C062BE

Q24603648-BECEDED0-10C5-4380-9231-ADF465B26126

P5008

Q24603648-637CCD85-AC6E-4428-9057-C969684FBA27

P577

Q24603648-8A7E5AF6-AA35-40C7-A7DB-87BBEDF708CD

Q24603648-EFECE523-3488-418E-945F-0734F438CD9C

P5875

Q24603648-37A65364-484B-4B7A-874A-6AE58FE331A4

P6179

Q24603648-AD749112-A2B5-40C9-8DF1-FFD88D9365EC

P698

Q24603648-C81BB7B1-1386-4E8C-8BEE-98C33C864597

P921

Q24603648-1A5C2A9F-DC31-4FD0-93CE-E4790F272AFC

P932

Q24603648-7F3CD948-CE17-4A76-B57C-6FBA7986493A

P3181

P356

ARD.2011.151027

P1433

Annals of the Rheumatic Diseases

P1476

2010 update of the ASAS/EULAR ...... ment of ankylosing spondylitis

@en

P2093

B Dijkmans

http://www.w3.org/2001/XMLSchema#string

Bj van Royen

http://www.w3.org/2001/XMLSchema#string

C van Drogen

http://www.w3.org/2001/XMLSchema#string

D Wendling

http://www.w3.org/2001/XMLSchema#string

E Collantes-Estevez

http://www.w3.org/2001/XMLSchema#string

E Stanislawska-Biernat

http://www.w3.org/2001/XMLSchema#string

H Boehm

http://www.w3.org/2001/XMLSchema#string

H Dagfinrud

http://www.w3.org/2001/XMLSchema#string

I Olivieri

http://www.w3.org/2001/XMLSchema#string

J Braun

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Epidemiology and reporting characteristics of systematic reviews

Physiotherapy interventions for ankylosing spondylitis

Methotrexate for ankylosing spondylitis

Sulfasalazine for ankylosing spondylitis

How Quickly Do Systematic Reviews Go Out of Date? A Survival Analysis

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Undifferentiated spondyloarthritis: a longterm followup

Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis

Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials.

Surgical outcome after spinal fractures in patients with ankylosing spondylitis

P304

896-904

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

332328

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/ARD.2011.151027

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Désirée van der Heijde

P5008

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51096060

http://www.w3.org/2001/XMLSchema#string

P6179

1034452504

http://www.w3.org/2001/XMLSchema#string

P698

21540199

http://www.w3.org/2001/XMLSchema#string

P921

ankylosing spondylitis

P932

3086052

http://www.w3.org/2001/XMLSchema#string